Skip to main content

Table 4 Patient response to trial invitation

From: Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)

Patient sex Total number of patients invited Response to invitation
EOI No May in future No response
Female 72,644 11,146 (15.3%)1 14,905 (20.5%) 1886 (2.6%) 44,707 (61.5%)
Male 116,231 27,625 (23.8%)2 19,274 (16.6%) 2918 (2.5%) 66,414 (57.1%)
  1. Numbers in brackets show the percentage of total invited 1females or 2males respectively for each response to invitation